ISPE Gathers Global Aseptic Leaders to Discuss Trends, Innovations, & COVID-19 Impact

28 January, 2021

ISPE announced its 2021 ISPE Aseptic Conference, taking place virtually on 15–17 March 2021. Now in its 30th year, this signature event has established itself as the pharmaceutical industry's leading source on advancing aseptic and barrier operations and providing invaluable opportunities for peer-to-peer learning through interactions with industry and regulatory leaders.

Sterile dosage forms will overtake all other dosage forms in the next few years in terms of value, and the conversations that take place during the ISPE Aseptic Conference are really where the shape of the pharmaceutical industry forms. The education agenda this year will address the most pressing industry concerns and interests, including Annex 1, advanced therapy medicinal products, robotics, and COVID impact.

Jörg Zimmermann

Vice President, Vetter Development Service, External Affairs
Vetter Pharma-Fertigung GmbH & Co.
2021 ISPE Aseptic Conference Chair

Keynote Speakers:

Rick Friedman
Deputy Director, Office of Manufacturing Quality
CDER/FDA
Jean Hu-Primmer
Global Regulatory Lead
GSK Vaccines

Featured Speakers:

Thomas J. Arista
Consumer Safety Officer
FDA/ORA
Brooke Higgins
Senior Policy Advisor, Office of Manufacturing Quality, Division of Drug Quality
FDA/CDER/OC/OMQ
Robert Sausville
Director, Div. Case Management
FDA/CBER/OMPT/OCBQ
David Doleski
Compliance Head for Biologics Quality Operations
Sanofi
James L. Drinkwater, PE
Head of GMP Compliance, F. Ziel GmbH, Chair, Annex 1 Focus Group, PHSS
F. Ziel GmbH
Markus Lesch, PhD
Head of Microbiological Validation
Vetter Pharma-Fertigung GmbH & Co KG

The ISPE Aseptic Conference has been setting the pace for the evolution of sterile manufacturing processes and technologies in the pharmaceutical industry for 30 years. The virtual conference platform will provide a unique opportunity for expanded global participation, both by speakers and attendees.

Learn More & Register